Sertraline does not alter steady-state concentrations or renal clearance of lithium in healthy volunteers. 1992

G Apseloff, and K D Wilner, and D A von Deutsch, and E B Henry, and L M Tremaine, and N Gerber, and J D Lazar
Department of Pharmacology, Ohio State University College of Medicine, Columbus 43210.

An open-label, placebo-controlled study was conducted to determine the effects of sertraline on the steady-state levels and renal clearance of lithium in 20 healthy volunteers. Subjects received 600 mg of lithium twice daily for 9 days. On the evening of day 8, subjects received orally either placebo or 100 mg of sertraline; these were administered twice, 8 hours apart, beginning 2 hours after the evening dose of lithium. In a comparison of day 8 with day 9 (before administration of the morning doses of lithium), sertraline was associated with only a 0.01 mEq/L (1.4%) decrease in steady-state levels and a 0.11 L/hour (6.9%) increase in the renal clearance of lithium. Neither change was statistically significant relative to placebo. Four subjects were excluded from analysis because of protocol violations or laboratory abnormalities unrelated to sertraline. Seven subjects who received lithium plus sertraline experienced side effects, mainly tremors, possibly related to treatment, whereas none of those administered lithium plus placebo experienced side effects. No sertraline-related laboratory abnormalities were observed.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014202 Tremor Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE. Action Tremor,Intention Tremor,Resting Tremor,Coarse Tremor,Continuous Tremor,Darkness Tremor,Fine Tremor,Intermittent Tremor,Involuntary Quiver,Massive Tremor,Passive Tremor,Persistent Tremor,Pill Rolling Tremor,Rest Tremor,Saturnine Tremor,Senile Tremor,Static Tremor,Tremor, Limb,Tremor, Muscle,Tremor, Neonatal,Tremor, Nerve,Tremor, Perioral,Tremor, Semirhythmic,Action Tremors,Coarse Tremors,Continuous Tremors,Darkness Tremors,Fine Tremors,Intention Tremors,Intermittent Tremors,Involuntary Quivers,Limb Tremor,Limb Tremors,Massive Tremors,Muscle Tremor,Muscle Tremors,Neonatal Tremor,Neonatal Tremors,Nerve Tremor,Nerve Tremors,Passive Tremors,Perioral Tremor,Perioral Tremors,Persistent Tremors,Pill Rolling Tremors,Quiver, Involuntary,Rest Tremors,Resting Tremors,Saturnine Tremors,Semirhythmic Tremor,Semirhythmic Tremors,Senile Tremors,Static Tremors,Tremor, Action,Tremor, Coarse,Tremor, Continuous,Tremor, Darkness,Tremor, Fine,Tremor, Intention,Tremor, Intermittent,Tremor, Massive,Tremor, Passive,Tremor, Persistent,Tremor, Pill Rolling,Tremor, Rest,Tremor, Resting,Tremor, Saturnine,Tremor, Senile,Tremor, Static,Tremors
D015057 1-Naphthylamine A suspected industrial carcinogen (and listed as such by OSHA). Its N-hydroxy metabolite is strongly carcinogenic and mutagenic. 1-Aminonaphthalene,alpha-Naphthylamine,8-Aminonaphthalene,Naphthalidine,1 Aminonaphthalene,1 Naphthylamine,8 Aminonaphthalene,alpha Naphthylamine
D020280 Sertraline A selective serotonin uptake inhibitor that is used in the treatment of depression. Altruline,Apo-Sertraline,Aremis,Besitran,Gen-Sertraline,Gladem,Lustral,Novo-Sertraline,Rhoxal-sertraline,Sealdin,Sertraline Hydrochloride,Sertraline Hydrochloride (1S-cis)-Isomer,Zoloft,ratio-Sertraline,Apo Sertraline,Gen Sertraline,Hydrochloride, Sertraline,Novo Sertraline,Rhoxal sertraline,ratio Sertraline

Related Publications

G Apseloff, and K D Wilner, and D A von Deutsch, and E B Henry, and L M Tremaine, and N Gerber, and J D Lazar
January 1995, British journal of clinical pharmacology,
G Apseloff, and K D Wilner, and D A von Deutsch, and E B Henry, and L M Tremaine, and N Gerber, and J D Lazar
January 1996, The Journal of clinical psychiatry,
G Apseloff, and K D Wilner, and D A von Deutsch, and E B Henry, and L M Tremaine, and N Gerber, and J D Lazar
January 1995, British journal of clinical pharmacology,
G Apseloff, and K D Wilner, and D A von Deutsch, and E B Henry, and L M Tremaine, and N Gerber, and J D Lazar
April 1988, Neurology,
G Apseloff, and K D Wilner, and D A von Deutsch, and E B Henry, and L M Tremaine, and N Gerber, and J D Lazar
September 2000, British journal of clinical pharmacology,
G Apseloff, and K D Wilner, and D A von Deutsch, and E B Henry, and L M Tremaine, and N Gerber, and J D Lazar
January 1988, Journal of clinical pharmacology,
G Apseloff, and K D Wilner, and D A von Deutsch, and E B Henry, and L M Tremaine, and N Gerber, and J D Lazar
June 1997, Antimicrobial agents and chemotherapy,
G Apseloff, and K D Wilner, and D A von Deutsch, and E B Henry, and L M Tremaine, and N Gerber, and J D Lazar
January 2013, Journal of cardiovascular pharmacology,
G Apseloff, and K D Wilner, and D A von Deutsch, and E B Henry, and L M Tremaine, and N Gerber, and J D Lazar
January 1998, Anesthesiology,
G Apseloff, and K D Wilner, and D A von Deutsch, and E B Henry, and L M Tremaine, and N Gerber, and J D Lazar
March 2010, Clinical chemistry and laboratory medicine,
Copied contents to your clipboard!